Join our host Evren Ozkaya as he welcomes ⁠Michael Altman⁠, VP of End-to-End US Supply Chain Operations at ⁠Kenvue ⁠for an insightful discussion on managing one of the largest disruptions of supply chain in the Pharma industry. This episode delves into the crucial balance between capital, cost and service/availability, the significance of an end-to-end supply chain view, and strategies for navigating disruptions, highlighted by lessons from the COVID-19 pandemic. Using the backdrop of the Tylenol supply chain disruption story during the early days of pandemic, Michael & Evren build on their recent HBR article “How Kenvue De-risked Its Supply Chain”. Michael shares his extensive experience and strategies for building resilience and optimization of supply chain operations, offering invaluable insights for anyone looking to understand or improve Pharma supply chains in the face of significant disruptions.